Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 181,890 | 182,546 | 163,796 | 146,808 | 135,405 |
| Cost of Goods | 2,956 | 2,867 | 2,524 | 2,535 | 1,876 |
| Gross Profit | 178,934 | 179,679 | 161,272 | 144,273 | 133,529 |
| Operating Expenses | 154,629 | 133,948 | 126,204 | 115,308 | 102,736 |
| Operating Income | 25,261 | 46,598 | 35,592 | 29,500 | 31,669 |
| Other Income | 6,700 | 6,345 | 6,004 | 5,493 | 5,139 |
| Pre-tax Income | 31,961 | 52,943 | 41,596 | 34,993 | 36,808 |
| Income Tax | 1,215 | 5,730 | 6,108 | 7,231 | 5,453 |
| Net Income Continuous | 30,746 | 47,213 | 35,488 | 27,762 | 31,355 |
| Net Income | $30,746 | $47,213 | $35,488 | $27,762 | $31,355 |
| EPS Basic Total Ops | 0.29 | 0.45 | 0.34 | 0.27 | 0.29 |
| EPS Basic Continuous Ops | 0.30 | 0.46 | 0.34 | 0.27 | 0.30 |
| EPS Diluted Total Ops | 0.25 | 0.41 | 0.32 | 0.25 | 0.27 |
| EPS Diluted Continuous Ops | 0.26 | 0.42 | 0.32 | 0.25 | 0.28 |
| EPS Diluted Before Non-Recurring Items | 0.26 | 0.41 | 0.32 | N/A | N/A |
| EBITDA(a) | $14,783 | $47,097 | $35,790 | $29,679 | $22,813 |